Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Benefits of GPS for people with dementia

As part of the norwegian research project "Trygge Spor", more than fifty dementia sufferers have been using GPS for periods varying from several weeks to up to a year. The results show that localisation technology helps achieve an increased sense of security, freedom and quality of life, both for sufferers and their next of kin.

29 Jan 2013

Study sheds new light on learning and memory-making

In experiments on rats outfitted with tiny goggles, scientists say they have learned that the brain's initial vision processing center not only relays visual stimuli, but also can "learn" time intervals and create specifically timed expectations of future rewards.

28 Jan 2013

Alzheimer's Association, SNMMI publish appropriate use criteria for brain amyloid imaging with PET

Only recently has it become possible to create high-quality images of the brain plaques characteristic of Alzheimer's disease in living people through positron emission tomography (PET). Even so, questions remain about what can be learned from these PET images and which people should have this test.

28 Jan 2013

UMDNJ-School of Osteopathic Medicine to develop blood test that can diagnose MCI

The Biomarker Discovery Center at the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine has been awarded a three-year, $799,800 grant from the Osteopathic Heritage Foundation to develop a blood test that can diagnose mild cognitive impairment (MCI) caused by early-stage Alzheimer's disease.

28 Jan 2013

Antibiotic use common at the end of life

More than one-quarter of hospice patients receive antibiotics in their last week of life, despite the absence of documented infection in most cases, US researchers report.

25 Jan 2013

Ohio State's Wexner Medical Center performs DBS surgery on Alzheimer's patient

During a five-hour surgery last October at The Ohio State University Wexner Medical Center, Kathy Sanford became the first Alzheimer's patient in the United States to have a pacemaker implanted in her brain.

25 Jan 2013

Keeping active can slow down memory loss in Alzheimer's patients

Keeping active can slow down the progression of memory loss in people with Alzheimer's disease, a study has shown.

25 Jan 2013

Researchers discover unique hairpin-like structure that facilitates Abeta clumping

Alzheimer's disease is the most common cause of late-life dementia. The disorder is thought to be caused by a protein known as the amyloid-beta protein, or Abeta, which clumps together in the brain, forming plaques that are thought to destroy neurons. This destruction starts early, too, and can presage clinical signs of the disease by up to 20 years.

24 Jan 2013

Hyperbaric treatment restores neurological function in damaged brains

Stroke, traumatic injury, and metabolic disorder are major causes of brain damage and permanent disabilities, including motor dysfunction, psychological disorders, memory loss, and more. Current therapy and rehab programs aim to help patients heal, but they often have limited success.

23 Jan 2013

Salk Institute to establish Helmsley Center for Genomic Medicine

The Salk Institute for Biological Studies has received a $42 million gift-the largest in the Institute's history-to establish the Helmsley Center for Genomic Medicine (HCGM), a research center dedicated to decoding the common genetic factors underlying many complex chronic human diseases.

23 Jan 2013

UCLA researchers identify abnormal tau proteins associated with sports-related concussions

Sports-related concussions and mild traumatic brain injuries have grabbed headlines in recent months, as the long-term damage they can cause becomes increasingly evident among both current and former athletes. The Centers for Disease Control and Prevention estimates that millions of these injuries occur each year.

23 Jan 2013

Cytos announces Novartis termination from NIC002 smoking cessation project

Cytos Biotechnology Ltd today announced that Novartis will discontinue the NIC002 project, which is a therapeutic vaccine candidate for the treatment of nicotine addiction.

23 Jan 2013

Amyloid clue to Parkinson’s dementia

Study findings link amyloid β burden to future cognitive decline in patients with Parkinson’s disease.

22 Jan 2013

Family members with rare gene mutation at high risk of developing schizophrenia

Johns Hopkins researchers have identified a rare gene mutation in a single family with a high rate of schizophrenia, adding to evidence that abnormal genes play a role in the development of the disease.

22 Jan 2013

Hearing loss is associated with accelerated cognitive decline and impairment in older adults

Hearing loss appears to be associated with accelerated cognitive decline and cognitive impairment in a study of older adults, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.

22 Jan 2013

Biophysical Society Annual Meeting to highlight innovations in medicine, physics, and more

Honeybee silk-inspired materials; a deconstruction of the Ebola virus; how microbes evolve resistance to antibiotics; and a possible connection between Alzheimer's disease and type II diabetes are just some of the intriguing topics that will be presented at the 57th Annual Meeting of the Biophysical Society (BPS).

22 Jan 2013

New study: Loneliness can harm overall health

New research links loneliness to a number of dysfunctional immune responses, suggesting that being lonely has the potential to harm overall health.

20 Jan 2013

New model of tau pathology spread

Brain diseases associated with the misformed protein tau, including Alzheimer's disease and frontotemporal lobar degeneration with tau pathologies, are characterized by neurofibrillary tangles (NFTs) comprised of pathological tau filaments.

19 Jan 2013

RSAS honors Feinstein Institute scientist with Crafoord Prize for genetic research on arthritis

The Royal Swedish Academy of Sciences announced today that Peter K. Gregersen , MD, a scientist at The Feinstein Institute for Medical Research, will receive the prestigious Crafoord Prize for his genetic research in the area rheumatoid arthritis.

18 Jan 2013

Children's Oakland recruits patients for deferiprone clinical trial to treat PKAN

A groundbreaking, international clinical trial of an iron chelation drug, deferiprone, to treat the rare and devastating neurodegenerative disease, pantothenate kinase-associated neurodegeneration (PKAN), began last month at the trial's only North American site, Children's Hospital & Research Center Oakland.

17 Jan 2013

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Benefits of GPS for people with dementia

Study sheds new light on learning and memory-making

Alzheimer's Association, SNMMI publish appropriate use criteria for brain amyloid imaging with PET

UMDNJ-School of Osteopathic Medicine to develop blood test that can diagnose MCI

Antibiotic use common at the end of life

Ohio State's Wexner Medical Center performs DBS surgery on Alzheimer's patient

Keeping active can slow down memory loss in Alzheimer's patients

Researchers discover unique hairpin-like structure that facilitates Abeta clumping

Hyperbaric treatment restores neurological function in damaged brains

Salk Institute to establish Helmsley Center for Genomic Medicine

UCLA researchers identify abnormal tau proteins associated with sports-related concussions

Cytos announces Novartis termination from NIC002 smoking cessation project

Amyloid clue to Parkinson’s dementia

Family members with rare gene mutation at high risk of developing schizophrenia

Hearing loss is associated with accelerated cognitive decline and impairment in older adults

Biophysical Society Annual Meeting to highlight innovations in medicine, physics, and more

New study: Loneliness can harm overall health

New model of tau pathology spread

RSAS honors Feinstein Institute scientist with Crafoord Prize for genetic research on arthritis

Children's Oakland recruits patients for deferiprone clinical trial to treat PKAN

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in